KORU Medical Systems, Inc.
General ticker "KRMD" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $165.3M (TTM average)
KORU Medical Systems, Inc. follows the US Stock Market performance with the rate: 58.4%.
Estimated limits based on current volatility of 2.9%: low 4.62$, high 4.90$
Factors to consider:
- Earnings expected soon, date: 2026-03-12 bmo
- Total employees count: 80 (-2.4%) as of 2024
- US accounted for 81.8% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Failure to innovate, Supply chain disruptions, Public health crises, Regulatory and compliance, Product liability
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.50$, 5.53$]
- 2025-12-31 to 2026-12-31 estimated range: [2.53$, 5.50$]
Financial Metrics affecting the KRMD estimates:
- Positive: with PPE of -39.2 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -0.18 <= 0.01
- Positive: 42.68 < Shareholder equity ratio, % of 61.77 <= 64.29
- Positive: Inventory ratio change, % of -3.19 <= -0.75
- Positive: -4.43 < Investing cash flow per share per price, % of -0.74
- Positive: -9.07 < Industry operating profit margin (median), % of -7.19
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: -0.01 < Industry operating cash flow per share per price (median), % of 0.78
Short-term KRMD quotes
Long-term KRMD plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $27.90MM | $28.52MM | $33.65MM |
| Operating Expenses | $38.68MM | $38.79MM | $40.09MM |
| Operating Income | $-10.78MM | $-10.27MM | $-6.45MM |
| Non-Operating Income | $0.11MM | $0.50MM | $0.38MM |
| R&D Expense | $4.96MM | $5.74MM | $5.26MM |
| Income(Loss) | $-10.68MM | $-9.77MM | $-6.06MM |
| Taxes | $-2.01MM | $3.97MM | $0.00MM |
| Profit(Loss)* | $-8.66MM | $-13.74MM | $-6.07MM |
| Stockholders Equity | $31.33MM | $20.35MM | $16.81MM |
| Inventory | $6.40MM | $3.48MM | $2.80MM |
| Assets | $42.33MM | $28.46MM | $27.22MM |
| Operating Cash Flow | $-5.40MM | $-4.89MM | $-0.32MM |
| Capital expenditure | $2.80MM | $0.81MM | $1.30MM |
| Investing Cash Flow | $-2.80MM | $-0.81MM | $-1.33MM |
| Financing Cash Flow | $0.28MM | $-0.22MM | $-0.25MM |
| Earnings Per Share** | $-0.19 | $-0.30 | $-0.13 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.